EFFECT OF BACILLUS CLAUSII IN COMBINATION WITH PHOTOTHERAPY IN THE TREATMENT OF NEONATAL HYPERBILIRUBINEMIA: A QUASI-EXPERIMENTAL STUDY IN A TERTIARY CARE HOSPITAL

Authors

  • Hina Batool Siddiqui Department of Pediatrics, PAF Mushaf, Sargodha, Pakistan
  • Abeer Asif Department of Paediatrics, PAF Hospital Mushaf, Sargodha, Pakistan
  • Attia Bano Department of Paediatrics, THQ Hospital Kahuta, Pakistan
  • Saba Mushtaq Department of Paediatrics, POF Hospital Wah Cantt, Pakistan
  • Nadia Bashir Department of Paediatrics, Niazi Medical & Dental College, Sargodha, Pakistan
  • Shanzay Nahal Department of Paediatrics, PAF Hospital Mushaf, Sargodha, Pakistan

DOI:

https://doi.org/10.69656/pjp.v22i1.1909

Keywords:

Bacillus clausii, Bilirubin, Hyperbilirubinemia, Neonatal Jaundice, Phototherapy, Probiotics

Abstract

Background: Neonatal hyperbilirubinemia is common in the first week of life, and probiotics like Bacillus clausii are gaining popularity in bilirubin clearance by modulating gut flora, and shown in previous studies to be safe and well-tolerated in newborns. The aim of this study was to compare the distribution of serum bilirubin levels between neonates receiving phototherapy alone and those receiving phototherapy plus Bacillus clausii. Methods: This quasi-experimental study using alternate allocation was conducted over six months from 1st Jan to 30th Jun 2025 in the Paediatric Department of PAF Hospital Mushaf, Sargodha. Eighty neonates were assigned to receive either phototherapy with Bacillus clausii (Group A) or phototherapy alone (Group B). Serum bilirubin levels were measured twice daily and finally evaluated on day four of treatment and compared between the groups. Results: Baseline characteristics were comparable between both treatment groups. Post-therapy serum bilirubin levels were significantly lower in the combined therapy group ‘A’ compared to the monotherapy group ‘B’ [median 4.0 (IQR 3.25–6.0) versus. 6.0 (IQR 4.0–9.0); p<0.001]. The effect size indicated a moderate treatment effect (r=0.40), favouring the combined therapy approach. Conclusion: Combining Bacillus clausii with phototherapy appears to be a safe and effective approach for managing neonatal hyperbilirubinemia. This combination not only accelerates bilirubin clearance but may also help reduce the duration of phototherapy.

Pak J Physiol 2026;22(1):33–6, DOI: https://doi.org/10.69656/pjp.v22i1.1909

Downloads

Download data is not yet available.

References

Ashwini S, Pabbati JL, Kumar BR, Yendamuri RM. A study on role of probiotics as an adjuvant therapy in the management of neonatal hyperbilirubinemia. Eur J Cardiovasc Med 2023;13(3):911–17. doi: https://doi.org/10.5083/ejcm/2023

Sarwar I, Ayaz A, Ammir K, Bashir N, Muhammad T, Langah A. Etiological risk factors for neonatal jaundice. J Peoples Uni Med Health Sci 2022;12(1):14–22. doi: https://doi.org/10.46536/ jpumhs/2022/12.01.344

Belay G, Gerbi A, Gebremariam T, Tilahun T, Chimdi E, Etefa T. Jaundice and its associated factors among neonates admitted to selected referral hospitals in southwest oromia, Ethiopia: Multi-center cross-sectional study. Heliyon 2023;9(5):e16019. doi: https://doi.org/10.1016/j.heliyon.2023.e16019.

Ansong-Assoku B, Adnan M, Daley SF, et al. Neonatal Jaundice. [Updated 2024 Feb 12]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026. Available from: https://www.ncbi.nlm.nih.gov/books/NBK532930/

Jaundice in newborn babies under 28 days. London: National Institute for Health and Care Excellence (NICE); 2023 Oct 31. (NICE Guideline, No. 98). Available from: https://www.ncbi.nlm.nih.gov/books/NBK553311/

van der Geest BAM, de Mol MJS, Barendse ISA, de Graaf JP, Bertens LCM, Poley MJ, et al. Assessment, management, and incidence of neonatal jaundice in healthy neonates cared for in primary care: a prospective cohort study. Sci Rep 2022;12(1):14385.

Shahid M, Zia A, Mazhar A, Hassan FQM, Shahid SM, Aslam N. Correlation between total serum bilirubin levels and transcutaneous bilirubinometer values in neonatal jaundice. Pak Postgrad Med J 2023;35(1):3–6.

Par EJ, Hughes CA, DeRico P. Neonatal Hyperbilirubinemia: Evaluation and Treatment. Am Fam Physician 2023;107:525–34.

Dani C, Fusco M, Andreini M, Pepe G, Pratesi S. Implementation of the 2022 AAP guidelines for neonatal hyperbilirubinemia could reduce the need for phototherapy in Italy. Ital J Pediatr 2025;51(1):162. doi: https://doi.org/10.1186/s13052-025-02002-x

Lai NM, Kamar AA, Lee SW, Ng KT, Fiander M, Cracknell J, et al. High?versus low?dose phototherapy for neonatal jaundice. Cochrane Database Syst Rev 2026;3(3):CD003308. doi: https://doi.org/10.1002/14651858.CD003308.pub3

Huang HM, Lin BH, Kang YN, Lai NM, Chen KH. Efficacy and safety of probiotic supplementation for neonatal jaundice: a systematic review and meta-analysis. Probiotics Antimicrob Prot 2025. doi: https://doi.org/10.1007/s12602-025-10795-w

WHO Sample Size Calculator. Available from: https://cdn.who.int/ media/docs/default-source/ncds/ncd-surveillance/steps/sample-size-calculator.xls

National Institute for Health and Care Excellence (NICE). Jaundice in newborn babies under 28 days [CG98]. London: NICE; 2010. [updated 2023 Oct; cited 2026 Mar 8]. Available from: www.nice.org.uk

Javadi F, Farhat AS, Saeidi R, Mohammadzadeh A, Bakhtiari E, Kordkatouli M. Effectiveness of probiotics in treating jaundice in low birth weight infants at Imam Reza Hospital. Zahedan J Res Med Sci 2025;27(4):e165142. doi: https://doi.org/10.5812/zjrms-165142

Santosa I, Shoji H, Itoh S, Shimizu T. Roles of probiotics in reduction of neonatal jaundice in term newborns. Juntendo Iji Zasshi 2022;68(2):140–6. doi: https://doi.org/10.14789/jmj.JMJ21-0044-OA

Waheed A, Shirazi H, Mustafa A, Waheed Y. Therapeutic effects of probiotics in the reduction of neonatal hyperbilirubinemia. Pak Armed Forces Med J 2024;74(1):113–6. doi: https://doi.org/ 10.51253/pafmj.v74i1.3071

Eghbalian F, Sabzehei MK, Talesh ST, Raeisi R, Jenabi E. The effect of probiotics on phototherapy for bilirubin reduction in term neonates: a randomized controlled trial. Curr Pediatr Rev 2024;21(1):85–90. doi: https://doi.org/10.2174/ 0115733963257942231024100105

Tariq B, Shahman M, Mateen A, Kamal MT, Ali AN, Shah AH. Role of probiotics in neonates with hyperbilirubinemia receiving phototherapy. Pak J Med Health Sci 2021;15:312–5. doi: https://doi.org/10.53350/pjmhs2115113112

Ain Q, Mahmood I, Manshah A. Efficacy of probiotics in reducing the severity and duration of neonatal hyperbilirubinemia. J Bacha Khan Med Coll 2024;5(2):116–21.

Deshmukh J, Deshmukh M, Patole S. Probiotics for the management of neonatal hyperbilirubinemia: a systematic review of randomized controlled trials. J Matern Fetal Neonatal Med 2019;32(1):154–63. doi: https://doi.org/10.1080/14767058.2017.1369520

Fatima M, Tufail U, Ahmed A, Waseem H, Simran FNU, Zafar M, et al. Efficacy of probiotics and synbiotics combined with phototherapy vs phototherapy alone in neonatal hyperbilirubinemia: a systematic review and meta-analysis of randomized controlled trials. Eur J Pediatr 2025;184(12):765. doi: https://doi.org/10.1007/s00431-025-06627-2

Downloads

Published

31-03-2026

How to Cite

1.
Batool Siddiqui H, Asif A, Attia Bano, Saba Mushtaq, Nadia Bashir, Shanzay Nahal. EFFECT OF BACILLUS CLAUSII IN COMBINATION WITH PHOTOTHERAPY IN THE TREATMENT OF NEONATAL HYPERBILIRUBINEMIA: A QUASI-EXPERIMENTAL STUDY IN A TERTIARY CARE HOSPITAL. Pak J Phsyiol [Internet]. 2026 Mar. 31 [cited 2026 Apr. 8];22(1):33-6. Available from: https://www.pjp.pps.org.pk/index.php/PJP/article/view/1909